Angiotensin II for the Treatment of Vasodilatory Shock | Zendy

Matthieu Jamme | Zendy; Alexandre Hertig | Zendy; Cédric Rafat | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Angiotensin II for the Treatment of Vasodilatory Shock

Author(s) -

Matthieu Jamme,

Alexandre Hertig,

Cédric Rafat

Publication year - 2017

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmc1714511

Subject(s) - medicine , vasodilation , angiotensin ii , shock (circulatory) , cardiology , blood pressure

1. Messé SR, Gronseth G, Kent DM, et al. Recurrent stroke with patent foramen ovale (update of practice parameter): report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 2016; 87: 815-21. 2. Ahmed N, Steiner T, Caso V, Wahlgren N. Recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 13–15 November 2016. Eur Stroke J 2017; 2: 95-102. 3. Eikelboom JW, Connolly SJ, Bosch J, et al. Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med 2017; 377: 1319-30.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research